Easywell Biomedicals (ROCO:1799) Cyclically Adjusted Book per Share: NT$11.02 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:1799 Easywell Biomedicals Inc ROCO:1799
55 GF Score
Price NT$32.25
GF Value NT$75.37
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Easywell Biomedicals Cyclically Adjusted Book per Share?

Easywell Biomedicals ROCO:1799 -5.43% 55 Cyclically Adjusted Book per Share is NT$11.02 as of Dec. 2025. GuruFocus rates ROCO:1799 with a GF Score™ of 55/100 and a GF Value™ of NT$75.37 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Easywell Biomedicals's adjusted book value per share for the three months ended in Dec. 2025 was NT$5.539. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is NT$11.02 for the trailing ten years ended in Dec. 2025.

During the past 12 months, Easywell Biomedicals's average Cyclically Adjusted Book Growth Rate was -14.00% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was -7.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was -4.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Easywell Biomedicals was -2.30% per year. The lowest was -7.40% per year. And the median was -3.30% per year.

As of today (2026-07-17), Easywell Biomedicals's current stock price is NT$32.25. Easywell Biomedicals's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 was NT$11.02. Easywell Biomedicals's Cyclically Adjusted PB Ratio of today is 2.93.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Easywell Biomedicals was 17.01. The lowest was 0.74. And the median was 1.68.


Easywell Biomedicals  (ROCO:1799) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Easywell Biomedicals's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=32.25/11.02
=2.93

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Easywell Biomedicals was 17.01. The lowest was 0.74. And the median was 1.68.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Easywell Biomedicals Cyclically Adjusted Book per Share Related Terms


Easywell Biomedicals Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Easywell Biomedicals's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Easywell Biomedicals Cyclically Adjusted Book per Share Chart

Easywell Biomedicals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.07 13.88 13.57 12.81 11.02

Easywell Biomedicals Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.81 12.43 12.00 11.54 11.02

ROCO:1799 vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Easywell Biomedicals's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Easywell Biomedicals Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Easywell Biomedicals's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Easywell Biomedicals's Cyclically Adjusted PB Ratio falls into.


ROCO:1799
55GF Score
Easywell Biomedicals Inc ROCO:1799
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Easywell Biomedicals Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Easywell Biomedicals's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book= Book Value per Share /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=5.539/324.0540*324.0540
=5.539

Current CPI (Dec. 2025) = 324.0540.

Easywell Biomedicals Quarterly Data

Book Value per Share CPI Adj_Book
201603 17.784 238.132 24.201
201606 16.699 241.018 22.452
201609 15.342 241.428 20.593
201612 15.834 241.432 21.253
201703 15.086 243.801 20.052
201706 14.158 244.955 18.730
201709 12.876 246.819 16.905
201712 13.629 246.524 17.915
201803 12.713 249.554 16.508
201806 12.000 251.989 15.432
201809 11.528 252.439 14.798
201812 10.245 251.233 13.215
201903 9.852 254.202 12.559
201906 8.952 256.143 11.325
201909 8.277 256.759 10.446
201912 7.607 256.974 9.593
202003 7.109 258.115 8.925
202006 7.862 257.797 9.883
202009 7.311 260.280 9.102
202012 7.137 260.474 8.879
202103 7.189 264.877 8.795
202106 8.379 271.696 9.994
202109 7.943 274.310 9.383
202112 7.556 278.802 8.782
202203 7.188 287.504 8.102
202206 6.937 296.311 7.586
202209 6.836 296.808 7.464
202212 6.387 296.797 6.974
202303 5.955 301.836 6.393
202306 5.754 305.109 6.111
202309 5.546 307.789 5.839
202312 5.231 306.746 5.526
202403 6.195 312.332 6.428
202406 6.075 314.175 6.266
202409 5.992 315.301 6.158
202412 5.900 315.605 6.058
202503 5.909 319.799 5.988
202506 5.233 322.561 5.257
202509 5.368 324.800 5.356
202512 5.539 324.054 5.539

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of NT$11.02 mean?
Easywell Biomedicals (ROCO:1799) has a Cyclically Adjusted Book per Share of NT$11.02 as of Dec. 2025. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Easywell Biomedicals and its competitors.
Is Easywell Biomedicals' Cyclically Adjusted Book per Share too high?
Easywell Biomedicals' current Cyclically Adjusted Book per Share is NT$11.02. Overall, Easywell Biomedicals has a GF Score™ of 55/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Easywell Biomedicals' Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Easywell Biomedicals' Cyclically Adjusted Book per Share of NT$11.02 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Easywell Biomedicals and its competitors. Easywell Biomedicals's current Cyclically Adjusted Book per Share is NT$11.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Easywell Biomedicals stock overvalued right now?
Based on GuruFocus' analysis, Easywell Biomedicals (ROCO:1799) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$75.37, compared to a current price of NT$32.25 — trading 57.2% below its estimated fair value. The current Cyclically Adjusted Book per Share is NT$11.02. Easywell Biomedicals' overall GF Score™ is 55/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Easywell Biomedicals (ROCO:1799), the current Cyclically Adjusted Book per Share is NT$11.02 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Easywell Biomedicals (ROCO:1799) Overvalued in 2026?

Based on GuruFocus' analysis, Easywell Biomedicals stock appears to be undervalued. The current stock price of NT$32.25 is trading 57.2% below its estimated GF Value™ of NT$75.37. GuruFocus considers Easywell Biomedicals to be Significantly Undervalued.

Key valuation signals for ROCO:1799:

  • Cyclically Adjusted Book per Share: NT$11.02
  • GF Value™: NT$75.37 vs. price of NT$32.25 (57.2% below fair value)
  • GF Score™: 55/100 with 3 warning signs

No single metric tells the full story. See the ROCO:1799 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Easywell Biomedicals Business Description

Address No.10, Yanfa 2nd Road, Hsinchu Science Park, 1st floor, Hsinchu, TWN, 30076
Easywell Biomedicals Inc is engaged in drug development, manufacturing, and sales of active pharmaceutical ingredients, generic drugs, and new drugs. It focuses on complex generics, new drug delivery platforms, and regenerative medicines, with cGMP. The company's segments include the Drug Development segment and the Other segment. Geographically, the company operates in America, China, and Taiwan regions.
55GF Score

Get the complete analysis for ROCO:1799

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$32.25
Price
NT$75.37
GF Value